These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 35416701)

  • 1. Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections.
    Sivori F; Cavallo I; Kovacs D; Guembe M; Sperduti I; Truglio M; Pasqua M; Prignano G; Mastrofrancesco A; Toma L; Pimpinelli F; Morrone A; Ensoli F; Di Domenico EG
    Microbiol Spectr; 2022 Apr; 10(2):e0035122. PubMed ID: 35416701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-biofilm activity of dalbavancin against methicillin-resistant
    Silva V; Miranda C; Bezerra M; Antão HS; Guimarães J; Prada J; Pires I; Maltez L; Pereira JE; Capelo JL; Igrejas G; Poeta P
    J Chemother; 2021 Nov; 33(7):469-475. PubMed ID: 33904369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
    Changchien CH; Chen SW; Chen YY; Chu C
    BMC Infect Dis; 2016 Jun; 16():276. PubMed ID: 27287530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015).
    Pfaller MA; Mendes RE; Sader HS; Castanheira M; Flamm RK
    J Glob Antimicrob Resist; 2017 Dec; 11():4-7. PubMed ID: 28735053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sub-inhibitory concentrations of nafcillin, vancomycin, ciprofloxacin, and rifampin on biofilm formation of clinical methicillin-resistant
    Park K-H; Kim D; Jung M; Kim DY; Lee Y-M; Lee MS; Hong K-W; Bae I-G; Hong SI; Cho O-H
    Microbiol Spectr; 2024 Jun; 12(6):e0341223. PubMed ID: 38651875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
    Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus.
    Yang W; Liu J; Blažeković B; Sun Y; Ma S; Ren C; Vladimir-Knežević S; Li C; Xing Y; Tian G; Wang Y
    BMC Complement Altern Med; 2018 May; 18(1):169. PubMed ID: 29848316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and Clinical Features of Heterogeneous Vancomycin-Intermediate
    Sreejisha M; Shenoy MS; Shenoy MS; Dhanashree B; Chakrapani M; Bhat KG
    Sultan Qaboos Univ Med J; 2023 Nov; 23(4):447-454. PubMed ID: 38090245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Bacterial Skin and Skin-Structure Infections, efficacy of Dalbavancin: a systematic review and meta-analysis.
    Monteagudo-Martínez N; Solís-García Del Pozo J; Nava E; Ikuta I; Galindo M; Jordán J
    Expert Rev Anti Infect Ther; 2022 Nov; 20(11):1477-1489. PubMed ID: 32981375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
    Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
    BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel small-molecule compound YH7 inhibits the biofilm formation of
    Xiao Y; Wan C; Wu X; Xu Y; Chen Y; Rao L; Wang B; Shen L; Han W; Zhao H; Shi J; Zhang J; Song Z; Yu F
    mSphere; 2024 Jan; 9(1):e0056423. PubMed ID: 38170984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms.
    Kebriaei R; Lehman SM; Shah RM; Stamper KC; Kunz Coyne AJ; Holger D; El Ghali A; Rybak MJ
    Microbiol Spectr; 2023 Jun; 11(3):e0491822. PubMed ID: 37199616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro effect of vancomycin and daptomycin on biofilm formation of coagulase-negative staphylococci strains].
    Öcal DN; Dolapçı İ; Gençtürk Z; Tekeli A
    Mikrobiyol Bul; 2017 Jul; 51(3):220-235. PubMed ID: 28929959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methicillin-resistant Staphylococcus aureus colonization of infectious and non-infectious skin and soft tissue lesions in patients in Tehran.
    Khalili H; Najar-Peerayeh S; Mahrooghi M; Mansouri P; Bakhshi B
    BMC Microbiol; 2021 Oct; 21(1):282. PubMed ID: 34657594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halicin Is Effective Against Staphylococcus aureus Biofilms In Vitro.
    Higashihira S; Simpson SJ; Collier CD; Natoli RM; Kittaka M; Greenfield EM
    Clin Orthop Relat Res; 2022 Aug; 480(8):1476-1487. PubMed ID: 35583504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital.
    Hashem AA; Abd El Fadeal NM; Shehata AS
    J Med Microbiol; 2017 Jun; 66(6):744-752. PubMed ID: 28598310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE).
    Knafl D; Tobudic S; Cheng SC; Bellamy DR; Thalhammer F
    Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):677-680. PubMed ID: 27896496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016).
    Pfaller MA; Flamm RK; Castanheira M; Sader HS; Mendes RE
    Int J Antimicrob Agents; 2018 Apr; 51(4):608-611. PubMed ID: 29277526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dalbavancin against methicillin-resistant Staphylococcus aureus in the rat granuloma pouch infection model.
    Jabés D; Candiani G; Romanó G; Brunati C; Riva S; Cavaleri M
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1118-23. PubMed ID: 15047510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.